The synthesis and antitumor activity of a novel didemnin B analogue contain
ing a Psi [CH2NH] amide bond surrogate between N-Me-D-Leu(7) and pro(8) are
reported. The analogue shows activity (GI(50) = 4 nM) comparable to that o
f didemnin B (GI(50) = 13 nM) in the NCI-60 tumor cell screen. This result,
along with new data from previously reported synthetic didemnin analogues,
is discussed within the context of the side-chain SAR for didemnins. (C) 2
001 Elsevier Science Ltd. All rights reserved.